Fibromyalgia: Clinical and occupational aspects

Revista da Associacao Medica Brasileira

Volumn 58, Issue 3, 2012, Pages 358-365

  Helfenstein, Milton ^a   Goldenfum, Marco Aurélio ^b,c   Siena, César Augusto Fávaro ^d  

^a FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

^b UNIVERSIDAD DE BUENOS AIRES   (Argentina)

^c Escola Superior de Gestão e Ciências da Saúde de Porto Alegre   (Brazil)

^d Federal Court Medical Expert of Ribeirão Preto   (Brazil)

Author keywords

Fibromyalgia; Occupational medicine; Referred pain; Review; Rheumatology

Indexed keywords

EID: 84864862276     PISSN: 01044230     EISSN: None     Source Type: Journal    
DOI: 10.1590/S0104-42302012000300018     Document Type: Review

References (68)

1. Smythe HA, Moldofsky H. Two contributions to understanding of the "fibrositis" syndrome. Bull Rheum Dis. 1977;28:928-31.
2. Yunus MB, Masi AT, Calabro JJ. Primary fibromyalgia (fibrositis). Clinical study of 50 patients with matched normal controls. Semin Arthritis Rheum. 1981;11:151-71.
3. Valentine M. Aetiology of fibrositis: a review. Ann Rheum Dis. 1947;6:241-50.
4. Wolfe F, Smithe HA, Yunus MB, Bennett RM, Bombardier C, Goldenberg DL, et al. The American College of Rheumatology 1990 criteria for the classification of fibromyalgia. Report of the multicenter Criteria Committee. Arthritis Rheum. 1990;33:160-72.
5. Wolfe F, Clauw DJ, Fitzcharles MA, Goldenberg DL, Katz RS, Mease P, et al. The American College of Rheumatology preliminary diagnostic criteria for fibromyalgia and measurement of symptom severity. Arthritis Care Res. 2010;62:600-10.
6. Wolfe F, Ross K, Anderson J, Russell IJ, Herbert I. The prevalence and characteristics of fibromyalgia in the general population. Arthritis Rheum. 1995;38:19-28.
7. Forseth KO, Gran JT. The prevalence of fibromyalgia among women aged 20-49 years in Aredal, Norway. Scand J Rheumatol. 1992;21:74-8.
8. Senna ER, De Barros AL, Silva EO, Costa IF, Pereira LV, Ciconelli RM, et al. Prevalence of rheumatic diseases in Brazil: a study using the COPCORD approach. J Rheumatol. 2004;31:594-7.
9. Forseth KO, Gran JT, Husby GA. A population study of the incidence of fibromyalgia among women aged 26-55 years. Br J Rheumatol. 1997; 36:1318-23.
10. Wolfe F. The relation between tender points and fibromyalgia symptom variables: evidence that fibromyalgia is not a discrete disorder in the clinic. Ann Rheum Dis. 1997;56: 268-71.
11. Berger A, Dukes E, Martin S, Edelsberg J, Oster G. Characteristics and healthcare costs of patients with fibromyalgia syndrome. Int J Clin Pract. 2007;61:1498-508.
12. Boonen A, Van Den Heuvel R, Van Tubergen A, Goossens M, Severens J, Van Der Heijde D, et al. Large differences in cost of illness and wellbeing between patients with fibromyalgia, chronic low back pain, or ankylosing spondylitis. Ann Rheum Dis. 2005;64:396-402.
13. Spaeth M. Epidemiology, costs, and the economic burden of fibromyalgia. Arthritis Res Ther. 2009;11:117-21.
14. Bradley LA, McKendree-Smith NL. Central nervous system mechanisms of pain in fibromyalgia and other musculoskeletal disorders: behavioral and psychologic treatment approaches. Curr Opin Rheumatol. 2002;14:45-51.
15. Buskila D, Neumann L. Fibromyalgia syndrome (FM) and nonarticular tenderness in relatives of patients with FM. J Rheumatol. 1997;24:941-4.
16. Arnold LM, Hudson JI, Hess EV, Ware AE, Fritz DA, Auchenbach MB, et al. Family study of fibromyalgia. Arthritis Rheum. 2004;50:944-52.
17. Crofford LJ, Demitrack MA. Evidence that abnormalities of central neurohormonal systems are key to understanding fibromyalgia and chronic fatigue syndrome. Rheum Dis Clin North Am. 1996;22:267-84.
18. Helfenstein M, Feldman D. Síndrome da fibromialgia: características clínicas e associações com outras síndromes disfuncionais. Rev Bras Reumatol. 2002;42:8-14.
19. Croft P, Schollum J, Silman A. Population study of tender point counts and pain as evidence of fibromyalgia. BMJ. 1994;309:696-9.
20. Cote KA, Moldofsky H. Sleep, daytime symptoms, and cognitive performance in patients with fibromyalgia. J Rheumatol. 1997;24:2014-23.
21. Zammit GK, Weiner J, Damato N, Sillup GP, McMillan CA. Quality of life in people with insomnia. Sleep. 1999;22:379-85.
22. Weidebach WFS. Fibromialgia: evidências de um substrato neurofisiológico. Rev Assoc Med Bras. 2002;48:291-5.
23. Raphael KG, Janal MN, Nayak S, Schwartz JE, Gallagher RM. Familial aggregation of depression in fibromyalgia: a community-based test of alternate hypotheses. Pain. 2004;110:449-60.
24. Nordahl HM, Stiles TC. Personality styles in patients with fibromyalgia, major depression and healthy controls. Ann Gen Psychiatry. 2007;6:9-13.
25. Da Costa PL, Dobkin M, Fitzcharles MA. The relationship between exercise participation and depressed mood in women with fibromyalgia. Psychol Health Med. 2001;6:301-11.
26. Berber JSS, Kupek E, Berber SC. Prevalência de depressão e sua relação com a qualidade de vida em pacientes com síndrome da fibromialgia. Rev Bras Reumatol. 2005;45:47-54.
27. Collado A, Alijotasb J, Benitoc P, Alegred C, Romerae M, Sañudof I, et al. Documento de consenso sobre el diagnóstico y tratamiento de la fibromialgia en Cataluña. Med Clin (Barc). 2002;118:745-9.
28. Bazzichi L, Rossi A, Giuliano T, Feo F, Giacomelli C, Consensi A, et al. Association between thyroid autoimmunity and fibromyalgic disease severity. Clin Rheumatol. 2007;26:2115-20.
29. Sulea AA, Leow MKS. Association of polycystic ovary syndrome and fibromyalgia in a patient with primary hyperparathyroidism: a novel triad? Clin Chem. 2006;52:1208-9.
30. Erkal M Z, Wilde J, Bilgin Y, Akinci A, Demir E, Bödeker RH, et al. High prevalence of vitamin D deficiency, secondary hyperparathyroidism and generalized bone pain in Turkish immigrants in Germany: identification of risk factors. Osteop Int. 2006;17:1133-40.
31. Al-Allaf AW, Mole PA, Paterson CR and Pullar T. Bone health in patients with fibromyalgia. Rheumatology. 2003;42:1202-6.
32. Nothnagl T, Leeb B. Diagnosis, differential diagnosis and treatment of polymyalgia rheumatica. Drugs Aging. 2006;23:391-402.
33. rded. Philadelphia: Verlag; 2008. p. 87-93.
34. Martínez-Lavín M. Overlap of fibromyalgia with other medical conditions. Curr Pain Headache Reports. 2007;5:347-50.
35. Kassan SS, Moutsopoulos HM. Clinical manifestations and early diagnosis of Sjögren syndrome. Arch Intern Med. 2004;164:1275-84.
36. Mascitelli L, Pezzetta F, Goldstein MR. Detrimental effect of statin therapy in women with fibromyalgia. Arch Intern Med. 2008;168:1228-9.
37. Eisinger J. Alcohol, thiamin and fibromyalgia. J Am Coll Nutr. 1998;17:300-2.
38. Kozanoglu E, Canataroglu A, Abayli B, Colakoglu S, Goncu K. Fibromyalgia syndrome in patients with hepatitis C infection. Rheumatol Int. 2004;23:248-51.
39. Adler GK, Manfredsdottir VF, Rackow RM. Hypothalamic-pituitary-adrenal axis function in fibromyalgia and chronic fatigue syndrome. Endocrinologist. 2002;12:513-24.
40. Gopaluni S, Thomas LM, Shah C. When myopathy strikes in a cancer patient. Gastrointest Cancer Res. 2009;3:212-4.
41. Friedberg F, Jason LA. Chronic fatigue syndrome and fibromyalgia: clinical assessment and treatment. J Clin Psychol. 2001;57:433-55.
42. McBeth J, Silman AJ. The role of psychiatric disorders in fibromyalgia. Curr Rheumatol Rep. 2001;3:157-64.
43. Winfield JB. Does pain in fibromyalgia reflect somatization? Arthritis Rheum. 2001;44:751-3.
44. Helfenstein M. Prevalência da síndrome da fibromialgia em pacientes diagnosticados como portadores de lesões por esforços repetitivos (LER) [tese]. São Paulo: Escola Paulista de Medicina; 1997.
45. Buckhardt CS, Goldenberg D, Crofford L, Gerwin R, Gowans S, Kugel P, et al. Guideline for the management of fibromyalgia syndrome pain in adults and children. APS Clinical Practice Guidelines Series, n. 4. Glenview: American Pain Society; 2005.
46. Leventhal LJ. Management of fibromyalgia. Ann Intern Med. 1999; 131:850-8.
47. Carville SF, Arendt-Nielsen S, Bliddal H, Blotman F, Branco JC, Buskila D, et al. EULAR evidence-based recommendations for the management of fibromyalgia syndrome. Ann Rheum Dis. 2008;67:536-41.
48. Clark P, Gentile MJ, Helfenstein M, Jannaut MJ, Liendo V, Ríos C, et al. Tratamiento farmacológico y no farmacológico de la fibromialgia-síntesis de la mejor evidencia. Drugs Today. 2011;47(Suppl A):1-28.
49. Arnold LM, Hudson JI, Wang F, Wohlreich MM, Prakash A, Kajdasz DK, et al. Comparisons of the efficacy and safety of duloxetine for the treatment of fibromyalgia in patients with versus without major depressive disorder. Clin J Pain. 2009;25:461-8.
50. Tofferi JK, Jackson JL, O'Malley PG. Treatment of fibromyalgia with cyclobenzaprine: a meta-analysis. Arthritis Care Res. 2004;51:9-13.
51. Nishishinya B, Urrútia G, Walitt B, Rodriguez A, Bonfill X, Alegre C, et al. Amitriptyline in the treatment of fibromyalgia: a systematic review of its efficacy. Rheumatology. 2008;47:1741-6.
52. Heymann RE, Paiva ES, Helfenstein M, Pollak DF, Martinez JE, Provenza JR, et al. Consenso brasileiro do tratamento da fibromialgia. Rev Bras Reumatol. 2010;50:56-66.
53. Sim J, Adams N. Systematic review of randomized controlled trials of nonpharmacological interventions for fibromyalgia. Clin J Pain. 2002;18:324-36.
54. Roizenblatt S, Neto NS, Tufik S. Sleep disorders and fibromyalgia. Curr Pain Headache Rep. 2011;15:347-57.
55. Whorton D, Weisenberger BI, Milroy WC. Does fibromyalgia qualify as a work-related illness or injury? J Occup Environ Med. 1992;34:968-72.
56. Bruusgaard D, Evensen AR, Bjerkedal T. Fibromyalgia-a new cause for disability pension. Scand J Soc Med. 1993;21:116-93.
57. Bennett RM. Disabling fibromyalgia: appearance versus reality. J Rheumatol. 1993;11:1821-5.
58. Romano TJ. Clinical experiences with post-traumatic fibromyalgia syndrome. West Virg Med J. 1990;86:198-202.
59. Moldofsky H, Wong MTH, Lue FA. Litigation, sleep, symptoms and disabilities in postaccident pain (fibromyalgia). J Rheumatol. 1993;20:1935-40.
60. Rainville JR, Sobel JB, Hartigan C. The effect of compensation involvement on the reporting of pain and disability by patients referred for rehabilitation of chronic low back pain. Spine.1997;22:2016-24.
61. Rohling ML, Binder LM, Langhinrichsen-Rohling JL. Money matters: a meta-analytic review of the association between financial compensation and the experience and treatment of chronic pain. Health Psychol. 1995;14:537-47.
62. Tait RC, Chibnall JT, Richardson WD. Litigation and employment status: effects on patients with chronic pain. Pain.1990;43:37-46.
63. nd ed. Edinburgh: Edinburgh University Press; 1982. p.174-224.
64. Bell DS. "Repetition strain injury": an iatrogenic epidemic of simulated injury. Med J Aust. 1989;151:280-4.
65. Boocock MG, McNair PJ, Larmer PJ, Armstrong B, Collier J, Simmonds M, et al. Interventions for the prevention and management of neck/upper extremity musculoskeletal conditions: a systematic review. Occup Environ Med. 2007;64:291-303.
66. Wolfe F, Potter J. Fibromyalgia and work disability: is fibromyalgia a disabling disorder? Rheum Dis Clin North Am. 1996;22:369-91.
67. Helfenstein M, Feldman D. Prevalência da síndrome da fibromialgia em pacientes diagnosticados como portadores de lesões por esforços repetitivos (LER). Rev Bras Reumatol. 1998;38:71-7.
68. Khostanteen I, Tunks ER, Goldsmith CH, Ennis J. Fibromyalgia: can one distinguish it from simulation? An observer-blind controlled study. J Rheumatol. 2000;27:2671-6.